MX2018010856A - Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional. - Google Patents
Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional.Info
- Publication number
- MX2018010856A MX2018010856A MX2018010856A MX2018010856A MX2018010856A MX 2018010856 A MX2018010856 A MX 2018010856A MX 2018010856 A MX2018010856 A MX 2018010856A MX 2018010856 A MX2018010856 A MX 2018010856A MX 2018010856 A MX2018010856 A MX 2018010856A
- Authority
- MX
- Mexico
- Prior art keywords
- value
- compositions
- devices
- testing methods
- functional dyspepsia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Optics & Photonics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Glass Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662305680P | 2016-03-09 | 2016-03-09 | |
| PCT/US2017/021643 WO2017156313A1 (en) | 2016-03-09 | 2017-03-09 | Compositions, devices, and methods of functional dyspepsia sensitivity testing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018010856A true MX2018010856A (es) | 2019-07-10 |
Family
ID=59789894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018010856A MX2018010856A (es) | 2016-03-09 | 2017-03-09 | Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20190120835A1 (https=) |
| EP (1) | EP3427056A4 (https=) |
| JP (2) | JP2019509485A (https=) |
| CN (1) | CN109154607A (https=) |
| AU (1) | AU2017230706A1 (https=) |
| CA (1) | CA3016735A1 (https=) |
| MX (1) | MX2018010856A (https=) |
| WO (1) | WO2017156313A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102224649B1 (ko) | 2014-11-14 | 2021-03-05 | 바이오메리카인코포레이티드 | Ibs 민감도 테스트 구성, 장치 및 방법 |
| WO2017156313A1 (en) * | 2016-03-09 | 2017-09-14 | Biomerica, Inc. | Compositions, devices, and methods of functional dyspepsia sensitivity testing |
| EP3497447B1 (en) | 2016-07-08 | 2024-09-04 | Biomerica, Inc. | Compositions, devices, and methods of depression sensitivity testing |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0310522D0 (en) * | 2003-05-08 | 2003-06-11 | Yorktest Lab Ltd | Assay panel |
| WO2005078442A1 (en) * | 2004-02-10 | 2005-08-25 | Dantini Daniel C | Comprehensive food allergy test |
| US7601509B2 (en) | 2004-07-15 | 2009-10-13 | Power Laura W | Biotype diets system: predicting food allergies by blood type |
| AR057828A1 (es) * | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
| WO2007099346A1 (en) * | 2006-03-03 | 2007-09-07 | Cambridge Antibody Technology Limited | Binding members for ghrelin |
| WO2009035529A1 (en) * | 2007-09-10 | 2009-03-19 | Immunohealth International, Llc | Method of analysis, detection and correction of food intolerance in humans |
| WO2010101255A1 (ja) * | 2009-03-05 | 2010-09-10 | 味の素株式会社 | クローン病診断試薬 |
| EP2533052A1 (en) * | 2011-06-07 | 2012-12-12 | B.R.A.H.M.S GmbH | Diagnostic use of proSomatostatin |
| CN104204807B (zh) * | 2012-01-20 | 2016-11-09 | 阿德莱德研究及创新控股有限公司 | 用于胃癌的生物标志物及其应用 |
| EP2657707A1 (en) * | 2012-04-26 | 2013-10-30 | B.R.A.H.M.S GmbH | Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope |
| KR102332418B1 (ko) * | 2015-01-30 | 2021-11-26 | 사이렉스 래보라토리즈 엘엘씨 | 다수의 식품 항원들 및 c1q-식품 단백질 면역 복합체에 대한 igg 항체 및 iga 항체의 동시 특징분석 |
| WO2017156313A1 (en) * | 2016-03-09 | 2017-09-14 | Biomerica, Inc. | Compositions, devices, and methods of functional dyspepsia sensitivity testing |
-
2017
- 2017-03-09 WO PCT/US2017/021643 patent/WO2017156313A1/en not_active Ceased
- 2017-03-09 JP JP2018547376A patent/JP2019509485A/ja active Pending
- 2017-03-09 CA CA3016735A patent/CA3016735A1/en active Pending
- 2017-03-09 CN CN201780025319.1A patent/CN109154607A/zh active Pending
- 2017-03-09 MX MX2018010856A patent/MX2018010856A/es unknown
- 2017-03-09 AU AU2017230706A patent/AU2017230706A1/en not_active Abandoned
- 2017-03-09 EP EP17764130.5A patent/EP3427056A4/en not_active Withdrawn
-
2018
- 2018-09-07 US US16/124,473 patent/US20190120835A1/en not_active Abandoned
-
2021
- 2021-12-10 JP JP2021201232A patent/JP2022031342A/ja active Pending
-
2025
- 2025-04-29 US US19/193,883 patent/US20260036579A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3427056A4 (en) | 2019-11-06 |
| US20260036579A1 (en) | 2026-02-05 |
| JP2022031342A (ja) | 2022-02-18 |
| US20190120835A1 (en) | 2019-04-25 |
| AU2017230706A1 (en) | 2018-09-27 |
| JP2019509485A (ja) | 2019-04-04 |
| EP3427056A1 (en) | 2019-01-16 |
| WO2017156313A1 (en) | 2017-09-14 |
| CA3016735A1 (en) | 2017-09-14 |
| CN109154607A (zh) | 2019-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017005773A2 (es) | Composiciones, dispositivos, y métodos de pruebas de sensibilidad del ibs | |
| BR112017007965A2 (pt) | método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit | |
| BR112018002848A2 (pt) | método, aparelho, mídia de armazenamento não transitório, programa de computador, kit para medir níveis de expressão de seis ou mais genes-alvo da via de sinalização celular | |
| MX2018005448A (es) | Metodos para la deteccion de apolipoproteinas. | |
| MX2016001719A (es) | Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular. | |
| BR112017012210A2 (pt) | solução conservante de célula, uso da mesma e método de produção de solução conservante de célula | |
| MX2016006125A (es) | Procedimiento, matriz y uso de los mismos. | |
| UY36223A (es) | Dispositivos para ensayos, métodos para realizar ensayos, kits para ensayos y método para fabricar dispositivos para ensayos | |
| MX2016016742A (es) | Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv). | |
| ECSP13013092A (es) | Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo | |
| MX2017010122A (es) | Composiciones y metodos para determinar el pronostico de cancer de endometrio. | |
| MX2018002947A (es) | Composiciones, dispositivos, y métodos de pruebas de sensibilidad a la osteoartritis. | |
| MX2018010856A (es) | Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional. | |
| MX2018007567A (es) | Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con psoriasis. | |
| MX2023005293A (es) | Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion. | |
| MX2018011166A (es) | Composiciones, dispositivos y metodos de prueba de sensibilidad de fibromialgia. | |
| MX2018015334A (es) | Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos a la enfermedad de reflujo gastroesofageal. | |
| MX2018013118A (es) | Composiciones, dispositivos y métodos de pruebas de sensibilidad a la enfermedad de crohn. | |
| MX2017006970A (es) | Metodo basado en celulas para determinar la potencia de la defibrotida. | |
| MX2016015531A (es) | Ensayo de inflamacion oral. | |
| MX2018013120A (es) | Composiciones, dispositivos y metodos de prueba de sensibilidad a la colitis ulcerosa. | |
| MX2023005604A (es) | Composiciones, dispositivos, y metodos de prueba de sensibilidad para el trastorno de deficit de atencion/trastorno de hiperactividad con deficit de atencion (add/adhd). | |
| MX2017007297A (es) | Composiciones y metodos para la introduccion de micronutrientes. | |
| MX2018007566A (es) | Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con dolor de cabeza por migraña. | |
| MX2019000143A (es) | Composiciones, dispositivos y métodos de prueba de sensibilidad a la depresión. |